Suchergebnisse - "Gonçalves, Antonio"

PubPharm (328)

21

Comparative Effectiveness of COVID-19 Vaccines in Preventing Infections and Disease Progression from SARS-CoV-2 Omicron BA.5 and BA.2, Portugal

enthalten in: Emerging infectious diseases | 2023

von Kislaya, I. | Casaca, P. | Borges, V. | +25

22

SARS-CoV-2 BA.5 vaccine breakthrough risk and severity compared with BA.2: a case-case and cohort study using Electronic Health Records in Portugal

enthalten in: bioRxiv.org | 2023

von Kislaya, I. | Casaca, P. | Borges, V. | +23

23

A Semi-mechanistic Model to Characterize the Long-Term Dynamics of Hepatitis B Virus Markers During Treatment With Lamivudine and Pegylated Interferon

enthalten in: Clinical pharmacology and therapeutics | 2023

von El Messaoudi, S. | Lemenuel-Diot, A. | Gonçalves, A. | +1

24

Transoral thyroid and parathyroid surgery in Brazil : where are we?

enthalten in: Revista do Colegio Brasileiro de Cirurgioes | 2023

von Tenório, L. | Bertelli, A. | Nakai, M. | +3

25

Thermoelectric Properties of Nickel and Selenium Co-Doped Tetrahedrite

enthalten in: Materials (Basel, Switzerland) | 2023

von Moço, D. | Malta, J. | Santos, L. | +2

26

Clinical and Pathophysiologic Insights of Free triiodothyronine/Free thyroxine Ratio in Patients with Heart Failure with Preserved Ejection Fraction : Data from the NETDiamond Cohort

enthalten in: Cardiology | 2023

von Leite, A. | Neves, J. | Angélico-Gonçalves, A. | +14

27

Outpatient 6-Hour Levosimendan Treatment as a Bridge to Heart Transplant

enthalten in: Arquivos brasileiros de cardiologia | 2023

von Gonçalves, A. | Reis, J. | Timóteo, A. | +9

28

A Semi‐mechanistic Model to Characterize the Long‐Term Dynamics of Hepatitis B Virus Markers During Treatment With Lamivudine and Pegylated Interferon

enthalten in: Clinical Pharmacology & Therapeutics | 2023

von El Messaoudi, S. | Lemenuel‐Diot, A. | Gonçalves, A. | +1

29

Early Decision Making in a Randomized Phase II Trial of Atezolizumab in Biliary Tract Cancer Using a Tumor Growth Inhibition‐Survival Modeling Framework

enthalten in: Clinical Pharmacology & Therapeutics | 2023

von Shemesh, C. | Chan, P. | Marchand, M. | +7

30

Population Pharmacokinetics and Exposure–Response Analysis for the CTLA‐4 Inhibitor Tremelimumab in Metastatic NSCLC Patients in the Phase III POSEIDON Study

enthalten in: Clinical Pharmacology & Therapeutics | 2023

von He, J. | Duval, V. | Jauslin, P. | +13